期刊名称：EPILEPSY RESEARCH
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Epilepsy Research provides for rapid publication of high quality articles in both experimental and clinical epileptology, where the principal emphasis of the research is concerned with brain mechanisms in epilepsy. It is intended to provide a forum for the many disciplines involved such as neurology, neurosurgery, neurophysiology, neuropharmacology, neurochemistry, neuroanatomy, neuropathology, neuroendocrinology, neurotoxicology, neurogenetics, neuroimaging, neuropsychology, neuropsychiatry, molecular neurobiology, clinical chemistry and paediatrics. As such the journal will publish original papers from any of these individual areas or studies of a multidisciplinary nature. Clinical and experimental research papers adopting fresh conceptual approaches to the study of epilepsy are encouraged. The overriding criteria for publication are novelty, significant clinical or experimental relevance, and interest to a multidisciplinary audience.
Audience
Epileptologists, neurologists, clinical neurophysiologists, pharmacologists, psychiatrists.
Abstracting / Indexing
- Chemical Abstracts
- Current Contents/Life Sciences
- EMBASE
- Elsevier BIOBASE
|
- Medline
- PubMed
- Reference Update
- Science Citation Index
|
Instructions to Authors
The journal will publish full-length original articles, full-length feature reviews or mini-reviews and short communications. Every effort will be made to notify authors about acceptance or rejection within 4 to 6 weeks. Book Reviews, Letters to the Editor and Abstracts of articles will be published at the Editors' discretion. Categories of manuscripts include:
(1) Full length papers: giving findings of original basic or clinical research in any area of epilepsy within the scope of the journal. These papers will be published within six months after acceptance.
(2) Short Communications: such as brief reports of research results which have reached a stage where they are ready for preliminary communication, or case reports of special relevance. Short communications will be published in the next available issue, usually within 3 months. They should not be more than 1500 words, or equivalent space including tables and figures.
(3) Review Articles: on specialised topics within the scope of the journal. Prospective authors should contact the Editors beforehand.
Submission of Papers
Manuscripts are published in English only and should be submitted in quadruplicate to one of the Managing Editors.
Manuscripts submitted to the Journal are only accepted on the understanding that:
(1) They deal with original research and are subject to editorial revision
(2) They have not been and will not be published in whole or in part in any other journal
(3) The recommendations from the Declaration of Helsinki and the internationally accepted principles in the care and use of experimental animals have been adhered to. Submission of a manuscript implies the transmission of copyright from the author to the publisher.
The preferred medium of final submission to the accepting Editor is on disk with the accompanying reviewed and revised manuscript. Manuscripts should be concisely written in a readily understandable style. Standard nomenclature should be used throughout; unfamiliar or new terms and arbitrary abbreviations should be defined when first used. Unnecessary abbreviations and 'laboratory slang' are to be avoided. The whole article should be typed with double line spacing. Each manuscript must have a separate title page which includes only the title, authors' full names, complete addresses of academic or professional affiliations, fax and e-mail details; the author to whom proofs and correspondence should be addressed should be indicated by an asterisk. The title should be short, clear and concise and should indicate the major point of the paper. The page following the title page should include an abstract of about 200 words for Full-Length Papers and 50-70 words for Short Communications, and up to six keywords.The remaining text should be organized as follows:
(1)Introduction.This should give the reasons for undertaking the study and a summary of the experimental plan. Exhaustive reviews of the literature should be avoided.
(2)Methods. These should be described in sufficient detail so that the work can be duplicated, or by reference to previous descriptions if they are readily available. Commonly used methods require only a citation of the original source unless they have been substantially modified. Statistical tests used for evaluation of data should be briefly explained. In case of experimental studies, animals used should be described, including information on breed, breeder, sex, age, weight and the maintenance conditions. Special chemicals and drugs with their sources should be grouped under a separate sub-heading ("Materials" or "Drugs"). For drugs, generic names should be used; trade names may be given in parentheses where the drug is first mentioned. In case of new drugs, a detailed chemical description (formula) should be given. The form of the drug used should be indicated.
(3) Results. In this section the findings should be described clearly, concisely, and in logical order without extended discussion of their significance. Only in the case of Short Communications, the Results and Discussion section may be combined. Results should usually be presented in graphic or tabular form, rather than discursively. There should be no duplication in text, tables and figures. Experimental conclusions should normally be based on adequate numbers of observations with statistical analysis of variance and the significance of differences. The number of individual values represented by a mean should be indicated.
(4) Discussion. This section should present conclusions to be drawn from the results accompanied by anassessment of their significance in relation to previous work. Speculative discussion is not discouraged, but the speculations hould be based on the data presented and identified as such. In general, the discussion should be as concise as possible.
(5) Acknowledgements. These may be included at the end of the Discussion section under a separate heading.
(6) References. Citation of literature references in the text should be given at the appropriate places by author(s) name(s) followed by the year in chronological order (Strunk and White, 1975; Gurman and Kniskern, 1981). With more than two authors, name only the first followed by "et al."(Paivio et al., 1975). When two or more papers by the same author(s) appear in one year, distinguish them by a, b, etc. after the date (Babb et al., 1984a,b). The author is responsible for accurate reference citation and the exact agreement between text and Reference List. All references cited in the text should be listed at the end of the paper on a separate page (also double-spaced), arranged in alphabetical order of the first author's names. Two or more references to the same author(s) should be in chronological order, according to the Harvard system. For references with three or more authors, which should be referred to as "et al."in the text, all names should be given in the reference list and these references should be arranged chronologically. Journal titles should be abbreviated according to Index Medicus. The form of literature reference should conform to the examples given below.
Paivio, A., Jansen, B., Becker, L.J., 1975. Comparisons through the mind's eye. Cognition 37, 635-647.
Strunk Jr., W., White, E.B., 1979. The Elements of Style, 3rd Ed. Macmillan, New York.
Gurman, A.S., Kniskern, D.P. (Eds.), Handbook of Family Therapy. Brunner/Maazel, New York, pp. 742-775
This journal should be cited in lists of references as Epilepsy Res.
(7) Presentation of data in Tables and Figures. In general, Tables and Figures should be so constructed that they, together with their captions and legends, will be intelligible with minimal reference to the text.
Tables
Each table should be on a separate page. Tables should be numbered consecutively with arabic numerals. The title of the Table should appear above it,legends, footnotes and statistical significance should be given below the body of the table.
Figures
Figures should be submitted in triplicate as unmounted glossy photographs and reach the editors in a form and condition suitable for reproduction either across a single column (=7.7 cm) or a whole page (=16.4cm). Lettering should be clear and of adequate size to be legible after reduction. Photographs, including roentgenograms, electroencephalograms, and electron micrographs, should be supplied as clear black and white prints on glossy paper, usually larger than the final size of reproduction, but not more than 20x25 cm. The degree of reduction will be determined by the publisher.The authors' names, the number and the orientation (top) of the Figure should be placed on the back of each photograph. Legends for Figures should be numbered consecutively in Arabic numerals and should appear on a separate page at the end of the manuscript. All symbols and abbreviations used in the Figure must be explained. Data in Tables and Figures should be presented as clearly defined mean values with some measure of their dispersion (standard deviation,standard error, range) and an appropriate indication of the statistical significance of differences from control values. The number of individual values represented by a mean should be indicated.
Electronic Manuscripts
Electronic manuscripts have the advantage that there is no need for the rekeying of text, thereby avoiding the possibility of introducing errors and resulting in reliable and fast delivery of proofs.
The preferred storage medium is a 5.25 or 3.5 inch disk in MS-DOS format, although other systems ate welcome, e.g. NEC and Macintosh (in this case, save your file in the usual manner, do not use the option "save in MS-DOS format"). Please do not split the article into separate files (title page as one file, text as another, etc.) Ensure that the letter "l" and the digit "1" (also letter "O" and digit "0") have been used properly, and format your article (tabs, indents, etc.) consistently. Characters not available on your word processor (Greek letters, mathematical symbols, etc.) should not be left open but indicated by a unique code (e.g., gralpha, @, #, etc., for the Greek letter ). Such codes should be used consistently throughout the entire text. Please make a list of such codes and provide a key. Do not allow your word processor to introduce word splits and do not use a "justified" layout. Please adhere strictly to the general instructions on style/arrangement and, in particular, the reference style of the journal. It is very important that you save your file in the word processor format. If your wordprocessor features the option to save files "in flat ASCII", please do not use it. Format your disk correctly and ensure that only the relevant file (one complete article only) is on the disk. Also, specify the type of computer and wordprocessing package used, label the disk with your name and the name of the file on the disk. After final acceptance, your disk plus one, final, printed and exactly matching version (as a printout) should be submitted together to the accepting editor. It is important that the file on disk and the printout are identical. Both will then be forwarded by the editor to Elsevier. Further information may be obtained from the publisher.
Colour Reproduction
Reproduction in colour will have to be approved by the Editor. Authors will be required to pay a fee towards the extra costs incurred in colour reproduction. The charges are Dfl. 600.00 (approx. USD 375) for the first page involving colour, and Dfl. 400.00 (approx. USD 250) per page for all subsequent pages involving colour in a given article (all prices including sales tax).
Colour figures should be submitted as separate prints and not be mounted on cardboard. Slides taken from labelled prints are also acceptable.
Proofs
Authors should keep a copy of their manuscripts as proofs will be sent to them without the manuscript. Proofs will usually be drawn on lower-quality paper. Only typesetting errors may be corrected; no change in, or additions to, the edited manuscript will be allowed at this stage.
Reprints
A total of 50 reprints of each paper will be provided free of charge to the author(s). Additional copies can be ordered at prices shown on a price list which will be sent to the authors with the proofs.
Page Charges
There will be no page charges.
(For complete up-to-date addresses of Editors please check the link to Editorial Board ).
Editorial Board
Managing Editors:
I.E. Leppik, Epilepsy Clinical Research Program, MINCEP Epilepsy Care, 5775 Wayzata Boulevard, Suite 255, Minneapolis, MN 55416, USA
W. Löscher, Department of Pharmacology, Toxicology and Pharmacy, School of Veterinary Medicine, Bünteweg 17, D-30559 Hannover, Germany
R.L. Macdonald, Department of Neurology, Vanderbilt University, 2100 Pierce Ave., Nashville, TN 37212, USA
D. Schmidt, Epilepsy Research Group, Goethestrasse 5, D-14163 Berlin, Germany
Book Review Editor:
G.L. Holmes, Dartmouth-Hitchcock Medical Ctr., One Medical Ctr. Drive, Lebanon, NH 03756, USA
Consulting Editors:
T.E. Albertson, Davis, CA, USA
G. Avanzini, Milan, Italy
C. Baumgartner, Vienna, Austria
C. Bazil, New York, NY, USA
G.K. Bergey, Baltimore, MD, USA
S.F. Berkovic, Heidelberg, VIC, Australia
N.G. Bowery, Birmingham, UK
O. Carter Snead, Toronto, ON, Canada
G.D. Cascino, Rochester, MN, USA
D. Chadwick, Liverpool, UK
S.J. Czuczwar, Lublin, Poland
R.J. Dingledine, Atlanta, GA, USA
A. Draguhn, Berlin, Germany
M.S. Duchowny, Miami, FL, USA
J.S. Duncan, Bucks, UK
C.E. Elger, Bonn, Germany
J. Engel Jr., Los Angeles, CA, USA
H.-H. Frey, Neustadt i.H, Germany
Y. Fukuyama, Tokyo, Japan
M. Gardiner, London, UK
B.E. Gidal, Madison, WI, USA
U. Heinemann, Berlin, Germany
C. Helmstaedter, Bonn, Germany
B. H. Hermann, Madison, WI, USA
G.L. Holmes, Lebanon, NH, USA
P.C. Jobe, Peoria, IL, USA
J. Kapur, Charlottesville, VA, USA
K. Kuriyama, Kyoto, Japan
J.K. Lee, Seoul, South Korea
D. Lowenstein, San Francisco, CA, USA
D.C. McIntyre, Ottawa, Canada
J.O. McNamara, Durham, NC, USA
B.S. Meldrum, London, UK
M. Morrell, New York, NY, USA
S.L. Mosh?/B>, Bronx, NY, USA
L. Nashef, London, UK
J.L. Noebels, Houston, TX, USA
V.M. Okujava, Tbilisi, Georgia
R.W. Olsen, Los Angeles, CA, USA
A. Pitkänen, Kuopio, Finland
D.A. Prince, Stanford, CA, USA
C.E. Ribak, Irvine, CA, USA
M.A. Rogawski, Bethesda, MD, USA
L. Sander, London, UK
S.C. Schachter, Boston, MA, USA
H. Scharfman, West Haverstraw, NY, USA
P.A. Schwartzkroin, Seattle, WA, USA
R.S. Sloviter, Tuscon, AZ, US
S.S. Spencer, New Haven, CT, USA
M.R. Sperling, Philadelphia, PA, USA
J. Stringer, Houston, TX, USA
T. Sutula, Madison, WI, USA
D. Vossler, Seattle, WA, USA
H.S. White, Salt Lake City, UT, USA
R.K.S. Wong, Brooklyn, NY, USA
|
